NCT02445391 2026-03-13
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
Clinical Trials
24 trialsNCT04001829 2026-03-13
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT05076266 2026-03-03
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Eastern Cooperative Oncology Group
Terminated
NCT03233191 2026-03-02
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
NCT03804255 2026-03-02
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Eastern Cooperative Oncology Group
Withdrawn
NCT04266249 2026-03-02
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT05108298 2026-03-02
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT05710328 2026-03-02
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT06112613 2026-03-02
Mobile Health for Adherence in Breast Cancer Patients
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT05896566 2026-02-24
PREcoopERA
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT07425002 2026-02-20
PRISM
Cancer Trials Ireland
Phase NA Recruiting
NCT07297667 2026-02-13
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Canadian Cancer Trials Group
Phase 1 Not yet recruiting
NCT05601440 2026-02-11
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT01674140 2026-02-10
e3
SWOG Cancer Research Network
Phase 3 Active not recruiting
NCT00066690 2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT07380971 2026-02-02
Developing a Comprehensive Exercise Service for Breast Cancer Process
GO fit Lab- Ingesport
Recruiting
NCT03624543 2026-01-30
CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Active not recruiting
NCT06995443 2026-01-30
REGAIN
Centre Hospitalier de Valenciennes
Phase NA Recruiting
NCT04316117 2026-01-26
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT03488693 2026-01-13
TAILOR RT
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT01840293 2025-12-19
Breast Cancer Proteomics and Molecular Heterogeneity
Cancer Trials Ireland
Recruiting
NCT02050750 2025-12-19
TAILORx Tissue Bank
Cancer Trials Ireland
Active not recruiting
NCT02352883 2025-12-19
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Eastern Cooperative Oncology Group
Phase NA Active not recruiting